| scholarly article | Q13442814 |
| P50 | author | Jens C Pruessner | Q51767545 |
| Pedro Rosa-Neto | Q56985526 | ||
| P2093 | author name string | Serge Gauthier | |
| Jonathan Dubois | |||
| Eduardo Rigon Zimmer | |||
| Antoine Leuzy | |||
| Alexey Kostikov | |||
| Jean-Paul Soucy | |||
| Cory Cooperman | |||
| Esther Schirmaccher | |||
| René Désautels | |||
| P2860 | cites work | RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention | Q24562489 |
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
| “Mini-mental state” | Q25938989 | ||
| Voxel-based morphometry–the methods | Q28138780 | ||
| Focal cortical presentations of Alzheimer's disease | Q28250737 | ||
| An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research | Q28278570 | ||
| Canadian Cardiovascular Society position statement on radiation exposure from cardiac imaging and interventional procedures | Q28298476 | ||
| The association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function | Q29977776 | ||
| Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data | Q30722226 | ||
| A nonparametric method for automatic correction of intensity nonuniformity in MRI data | Q32061718 | ||
| Motion correction of multi-frame PET data in neuroreceptor mapping: simulation based validation | Q33456336 | ||
| Neurons and their dendrites in frontotemporal dementia | Q33704839 | ||
| The prevalence of frontotemporal dementia | Q33959615 | ||
| Allosteric mechanisms of signal transduction | Q33987546 | ||
| Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update | Q34020227 | ||
| Distinct pathological subtypes of FTLD-FUS. | Q34024578 | ||
| Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. | Q34454591 | ||
| Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study | Q35085729 | ||
| In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model | Q35129804 | ||
| Glutamatergic systems in Alzheimer's disease. | Q35218753 | ||
| Metabotropic glutamate receptors. | Q36539070 | ||
| Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation | Q36840001 | ||
| Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells | Q37587515 | ||
| Altered glutamate neurotransmission and behaviour in dementia: evidence from studies of memantine | Q37659140 | ||
| Metabotropic glutamate receptors: physiology, pharmacology, and disease | Q37670222 | ||
| Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? | Q37764485 | ||
| Gray matter atrophy in behavioral variant frontotemporal dementia: a meta-analysis of voxel-based morphometry studies | Q38020748 | ||
| Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways | Q38330282 | ||
| Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale | Q38398448 | ||
| Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias | Q38430918 | ||
| Partial Volume Correction Strategies in PET. | Q38829222 | ||
| Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors | Q40027235 | ||
| Excitotoxicity hypothesis | Q41152589 | ||
| In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688. | Q41988368 | ||
| beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis | Q42492837 | ||
| Metabotropic glutamate receptor 5, but not 1, modulates NMDA receptor-mediated activation of neuronal nitric oxide synthase | Q43204024 | ||
| Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain | Q43713020 | ||
| In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride | Q44830953 | ||
| A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration | Q45754401 | ||
| Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. | Q46534517 | ||
| Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease | Q46617284 | ||
| Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride | Q46896544 | ||
| Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. | Q46920843 | ||
| Neurochemical features of frontotemporal dementia | Q48143141 | ||
| Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study | Q48247819 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease | Q48362827 | ||
| Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory | Q48436289 | ||
| Parametric imaging of ligand-receptor binding in PET using a simplified reference region model | Q48546793 | ||
| Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: a retrospective analysis | Q48735328 | ||
| Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan | Q56441169 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 1387-1402 | |
| P577 | publication date | 2015-01-18 | |
| P1433 | published in | Brain Structure and Function | Q13444883 |
| P1476 | title | In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD. | |
| P478 | volume | 221 |
| Q41468480 | Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET. |
| Q37347468 | Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688 |
| Q89895162 | G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits |
| Q91899824 | Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience |
| Q38690069 | Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging |
| Q47837913 | Neurotransmitter deficits from frontotemporal lobar degeneration |
| Q51765788 | Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment. |
| Q64102453 | Toward a Glutamate Hypothesis of Frontotemporal Dementia |
Search more.